In a double blind study , 262 DCC attendees ages 12 to 35 months were randomized to receive a 9-valent pneumococcal conjugate vaccine ( PnCRM9 ; n = 132 ) , or a control vaccine ( meningococcus C vaccine ; n = 130 ) .
